Dive Brief: Enveda Biosciences said Thursday it raised $150 million in Series D financing, doubling the cash it’s pulled in from venture capitalists t...

Dive Brief: Sanofi shares dropped after the French drugmaker reported results from a highly anticipated study of a new kind of medicine for eczema tha...

Dive Brief: The Food and Drug Administration plans to work more closely and flexibly with developers of drugs for certain ultra-rare conditions, outli...

Prolific biotechnology investment firm Atlas Venture said Thursday it raised $400 million to pump into its existing portfolio of drug startups, a move...

U.S. lawmakers clashed with Health and Human Services Secretary Robert F. Kennedy Jr. over his changes to the country’s vaccine policy and oversight o...

Dive Brief: More than 1,000 current and former HHS employees are calling on Robert F. Kennedy, Jr. to resign as Health and Human Services secretary, a...

Dive Brief: Argo Biopharma said Wednesday it’s entered a new collaboration with Novartis to develop RNA medicines for cardiovascular diseases. The dea...

Dive Brief: An experimental RNA editing medicine from Wave Life Sciences helped study participants with a rare liver and lung disease produce a protei...

For the past four years or so, veteran drug hunters Josh Bilenker and Jeff Engelman have kept tightly under wraps the details of their latest project,...

Biohaven’s top executive said his team is well-prepared to sell a therapy that could be not only the first approved medicine for a group of rare brain...